Literature DB >> 12701551

Stability of valganciclovir in extemporaneously compounded liquid formulations.

Carolyn C Henkin1, James C Griener, Andrew P Ten Eick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12701551     DOI： 10.1093/ajhp/60.7.687

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  3 in total

1.  Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection.

Authors:  G Lombardi; F Garofoli; P Villani; M Tizzoni; M Angelini; M Cusato; L Bollani; A De Silvestri; M Regazzi; M Stronati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-11       Impact factor: 3.267

2.  Pharmacokinetics of ganciclovir and valganciclovir in the adult horse.

Authors:  R J Carmichael; C Whitfield; L K Maxwell
Journal:  J Vet Pharmacol Ther       Date:  2013-01-10       Impact factor: 1.786

Review 3.  Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.

Authors:  Beth C Marshall; William C Koch
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.